In conclusion, our findings suggested that circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of NSCLC through the miR-182-5p/GRB2/FOXO1/FOXO3 signaling pathway, providing several potential therapeutic targets to overcome the Taxol resistance of NSCLC. Here, FOXO3 is linked to non-small cell lung carcinoma.